The landscape of dementia analysis has advanced considerably with the arrival of innovative biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. When these technological improvements signify remarkable development in knowing neurodegenerative diseases, they may https://janea097cmw7.activablog.com/profile